111 (NASDAQ:YI) Stock Price Down 2.2% – Should You Sell?

111, Inc. Sponsored ADR (NASDAQ:YI)’s stock price traded down 2.2% during trading on Wednesday . The company traded as low as $3.01 and last traded at $3.13. Approximately 1,657 shares traded hands during trading, a decline of 82% from the average daily volume of 8,994 shares. The stock had previously closed at $3.20.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, August 31st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, 111 presently has a consensus rating of “Sell”.

111 Stock Performance

The firm has a market cap of $27.51 million, a price-to-earnings ratio of -2.24 and a beta of 0.64. The stock has a 50-day moving average of $3.70 and a 200-day moving average of $5.22.

Insider Activity

In other news, Director Jian David Sun sold 111,100 shares of 111 stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $0.23, for a total value of $25,553.00. Following the sale, the director directly owned 472,011 shares in the company, valued at $108,562.53. This trade represents a 19.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 263,820 shares of company stock valued at $60,679 in the last 90 days. 43.90% of the stock is owned by company insiders.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.